[96a5a0]: / output / allTrials / identified / NCT02673060_identified.json

Download this file

375 lines (375 with data), 15.7 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
{
"info": {
"nct_id": "NCT02673060",
"official_title": "A Phase 1 Multicenter, Open-label, Dose-escalation Trial of MBC-11, an Etidronate-ara-C Conjugate in Patients With Malignant Tumors With Cancer-induced Bone Disease (CIBD)",
"inclusion_criteria": "* Histologically confirmed malignant tumor (breast cancer, prostate cancer etc)\n* Bone metastases, documented by radiographs, bone scan\n* No available standard chemotherapy or no indication for chemotherapy at the time of screening\n* Eastern Cooperative Oncology Group [ECOG] status 0-2\n* Adequate bone marrow function (hemoglobin ≥ 9 g/dL with or without transfusion requirement, absolute neutrophil count ≥ 1500/mm3, and platelets ≥ 75,000/mm3)\n* Adequate liver function (bilirubin ≤ 2 x Upper Limit of Normal [ULN], Alanine aminotransferase [ALT] ≤ 2.5 x ULN).\n* Adequate renal function (creatinine ≤ 1.5 x ULN) and creatinine clearance ≥ 50 mL/min [measured or calculated by nomogram]).\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Systemic chemotherapy and/or investigational therapy within the previous 4 weeks\n* Fracture ≤ 6 month prior the inclusion in the study\n* Brain metastasis\n* Serum calcium levels < 8.5 mg/dL (< 2.2 mmol/L)",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Histologically confirmed malignant tumor (breast cancer, prostate cancer etc)",
"criterions": [
{
"exact_snippets": "Histologically confirmed malignant tumor",
"criterion": "malignant tumor",
"requirements": [
{
"requirement_type": "confirmation method",
"expected_value": "histologically confirmed"
}
]
},
{
"exact_snippets": "breast cancer",
"criterion": "breast cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "prostate cancer",
"criterion": "prostate cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Bone metastases, documented by radiographs, bone scan",
"criterions": [
{
"exact_snippets": "Bone metastases, documented by radiographs, bone scan",
"criterion": "bone metastases",
"requirements": [
{
"requirement_type": "documentation",
"expected_value": [
"radiographs",
"bone scan"
]
}
]
}
]
},
{
"line": "* No available standard chemotherapy or no indication for chemotherapy at the time of screening",
"criterions": [
{
"exact_snippets": "No available standard chemotherapy",
"criterion": "standard chemotherapy",
"requirements": [
{
"requirement_type": "availability",
"expected_value": false
}
]
},
{
"exact_snippets": "no indication for chemotherapy at the time of screening",
"criterion": "indication for chemotherapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Eastern Cooperative Oncology Group [ECOG] status 0-2",
"criterions": [
{
"exact_snippets": "Eastern Cooperative Oncology Group [ECOG] status 0-2",
"criterion": "ECOG status",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 2,
"unit": "N/A"
}
]
}
}
]
}
]
},
{
"line": "* Adequate bone marrow function (hemoglobin ≥ 9 g/dL with or without transfusion requirement, absolute neutrophil count ≥ 1500/mm3, and platelets ≥ 75,000/mm3)",
"criterions": [
{
"exact_snippets": "Adequate bone marrow function (hemoglobin ≥ 9 g/dL ...",
"criterion": "hemoglobin",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 9,
"unit": "g/dL"
}
}
]
},
{
"exact_snippets": "Adequate bone marrow function ... with or without transfusion requirement",
"criterion": "transfusion requirement",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "Adequate bone marrow function ... absolute neutrophil count ≥ 1500/mm3",
"criterion": "absolute neutrophil count",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 1500,
"unit": "mm3"
}
}
]
},
{
"exact_snippets": "Adequate bone marrow function ... platelets ≥ 75,000/mm3",
"criterion": "platelets",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 75000,
"unit": "mm3"
}
}
]
}
]
},
{
"line": "* Adequate liver function (bilirubin ≤ 2 x Upper Limit of Normal [ULN], Alanine aminotransferase [ALT] ≤ 2.5 x ULN).",
"criterions": [
{
"exact_snippets": "Adequate liver function (bilirubin ≤ 2 x Upper Limit of Normal [ULN]",
"criterion": "bilirubin level",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": {
"operator": "<=",
"value": 2,
"unit": "x ULN"
}
}
]
},
{
"exact_snippets": "Alanine aminotransferase [ALT] ≤ 2.5 x ULN",
"criterion": "Alanine aminotransferase (ALT) level",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": {
"operator": "<=",
"value": 2.5,
"unit": "x ULN"
}
}
]
}
]
},
{
"line": "* Adequate renal function (creatinine ≤ 1.5 x ULN) and creatinine clearance ≥ 50 mL/min [measured or calculated by nomogram]).",
"criterions": [
{
"exact_snippets": "Adequate renal function (creatinine ≤ 1.5 x ULN)",
"criterion": "creatinine",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": {
"operator": "<=",
"value": 1.5,
"unit": "x ULN"
}
}
]
},
{
"exact_snippets": "creatinine clearance ≥ 50 mL/min",
"criterion": "creatinine clearance",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": {
"operator": ">=",
"value": 50,
"unit": "mL/min"
}
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Systemic chemotherapy and/or investigational therapy within the previous 4 weeks",
"criterions": [
{
"exact_snippets": "Systemic chemotherapy ... within the previous 4 weeks",
"criterion": "systemic chemotherapy",
"requirements": [
{
"requirement_type": "time since last treatment",
"expected_value": {
"operator": ">=",
"value": 4,
"unit": "weeks"
}
}
]
},
{
"exact_snippets": "investigational therapy within the previous 4 weeks",
"criterion": "investigational therapy",
"requirements": [
{
"requirement_type": "time since last treatment",
"expected_value": {
"operator": ">=",
"value": 4,
"unit": "weeks"
}
}
]
}
]
},
{
"line": "* Fracture ≤ 6 month prior the inclusion in the study",
"criterions": [
{
"exact_snippets": "Fracture ≤ 6 month prior the inclusion",
"criterion": "fracture",
"requirements": [
{
"requirement_type": "time since occurrence",
"expected_value": {
"operator": "<=",
"value": 6,
"unit": "month"
}
}
]
}
]
},
{
"line": "* Brain metastasis",
"criterions": [
{
"exact_snippets": "Brain metastasis",
"criterion": "brain metastasis",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Serum calcium levels < 8.5 mg/dL (< 2.2 mmol/L)",
"criterions": [
{
"exact_snippets": "Serum calcium levels < 8.5 mg/dL (< 2.2 mmol/L)",
"criterion": "serum calcium levels",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"comparisons": [
{
"operator": "<",
"value": 8.5,
"unit": "mg/dL"
},
{
"operator": "<",
"value": 2.2,
"unit": "mmol/L"
}
]
}
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}